Veris Residential insiders disclose $1.27M proposed sale; 500,000 shares sold recently

Rhea-AI Filing Summary

Veris Residential, Inc. (VRE) notice reports a proposed sale of 79,724 common shares through Morgan Stanley Smith Barney with an aggregate market value of $1,272,734.53. The filing shows total shares outstanding of 93,421,769, so the proposed sale represents a small fraction of the company’s share count. The filer acquired the shares in two open-market purchases on July 23–24, 2018 (42,965 and 36,759 shares) paid in cash.

The filing also discloses related sales during September 9–11, 2025 by entities identified as MIRELF VII US SECURITIES LLC and MIRELF VI REIT INVESTMENT II, LLC totaling 500,000 shares with gross proceeds shown for each trade. The filer certifies no undisclosed material adverse information.

Insights

Financial Analyst

TL;DR Proposed sale is modest versus outstanding shares; recent affiliated sales total 500,000 shares over three days.

The notice documents a planned sale of 79,724 shares valued at $1.27 million, representing roughly 0.085% of the reported 93.4 million shares outstanding. More notable are the disclosed affiliated sales of 500,000 shares on September 9–11, 2025, which collectively amount to about 0.54% of outstanding shares and generated multi-million dollar proceeds. For investors, the planned 79,724 sale alone is unlikely to pressure the stock materially, though the cluster of prior sales by related entities is a quantifiable supply event to consider when reviewing near-term trading activity.

Corporate Governance Expert

TL;DR The filing shows compliance with Rule 144 disclosures; multiple related-entity disposals were executed recently.

The Form 144 provides required disclosure for proposed insider/affiliate sales and documents the acquisition details (open-market purchases in July 2018) and cash payment. The signer attests no undisclosed material adverse information and the filing identifies the executing broker. The pattern of several sizable sales by MIRELF entities over September 9–11, 2025 suggests coordinated dispositions by affiliated holders; the filing itself complies with procedural requirements and increases transparency for shareholders.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	79724	1272734.53	93421769	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/23/2018	Open Market Purchase	Open Market			42965	07/25/2018	Cash
Common	07/24/2018	Open Market Purchase	Open Market			36759	07/26/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	114560	1840956.29
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	85440	1373003.71
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	85920	1378491.89
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	64080	1028093.11
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is the size and value of the proposed VRE sale in this Form 144?

The notice proposes to sell 79,724 shares with an aggregate market value of $1,272,734.53 via Morgan Stanley Smith Barney.

How many shares does Veris Residential have outstanding according to this filing?

The filing reports 93,421,769 shares outstanding.

When and how were the shares being sold acquired?

The shares were acquired in two open-market purchases on July 23, 2018 (42,965 shares) and July 24, 2018 (36,759 shares), with payment in cash.

Were there other sales of the issuer’s stock disclosed within the past three months?

Yes. Related entities (MIRELF VII US SECURITIES LLC and MIRELF VI REIT INVESTMENT II, LLC) sold a total of 500,000 shares on September 9–11, 2025, with gross proceeds reported for each trade.

Which broker is handling the proposed sale under Rule 144?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY.